Overview
Phyllodes tumor of the breast (also known as cystosarcoma phyllodes or phylloides tumor) is a rare fibroepithelial neoplasm of the breast that arises from the periductal stromal cells. These tumors account for less than 1% of all breast neoplasms and are classified by the World Health Organization into three categories: benign, borderline, and malignant, based on histological features including stromal cellularity, mitotic activity, stromal overgrowth, and tumor margins. Phyllodes tumors predominantly affect women, with a peak incidence in the fourth and fifth decades of life, though they can occur at any age after puberty. The most common clinical presentation is a rapidly growing, firm, well-circumscribed breast mass that may become quite large. Patients typically notice a painless lump that increases in size over weeks to months. Large tumors may cause skin stretching, visible veins, and occasionally skin ulceration. Unlike breast carcinomas, phyllodes tumors rarely spread to axillary lymph nodes, but malignant variants can metastasize hematogenously, most commonly to the lungs, bones, and liver. The primary treatment for phyllodes tumors is wide local excision with adequate surgical margins, as local recurrence is a significant concern, particularly with borderline and malignant subtypes. Mastectomy may be necessary for large tumors or when adequate margins cannot be achieved with breast-conserving surgery. The role of adjuvant radiation therapy remains debated but may be considered for borderline and malignant tumors to reduce local recurrence risk. Chemotherapy has limited efficacy and is generally reserved for metastatic disease. Most phyllodes tumors are sporadic, though rare associations with Li-Fraumeni syndrome (TP53 mutations) have been reported. Prognosis is generally favorable for benign and borderline tumors, while malignant phyllodes tumors carry a more guarded prognosis with potential for distant metastasis.
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
1 eventSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Phyllodes tumor of the breast.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Phyllodes tumor of the breast at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Phyllodes tumor of the breast.
Community
No community posts yet. Be the first to share your experience with Phyllodes tumor of the breast.
Start the conversation →Latest news about Phyllodes tumor of the breast
Disease timeline:
New recruiting trial: AI-Assisted System for Accurate Diagnosis and Prognosis of Breast Phyllodes Tumors
A new clinical trial is recruiting patients for Phyllodes tumor of the breast
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Phyllodes tumor of the breast
What is Phyllodes tumor of the breast?
Phyllodes tumor of the breast (also known as cystosarcoma phyllodes or phylloides tumor) is a rare fibroepithelial neoplasm of the breast that arises from the periductal stromal cells. These tumors account for less than 1% of all breast neoplasms and are classified by the World Health Organization into three categories: benign, borderline, and malignant, based on histological features including stromal cellularity, mitotic activity, stromal overgrowth, and tumor margins. Phyllodes tumors predominantly affect women, with a peak incidence in the fourth and fifth decades of life, though they can
How is Phyllodes tumor of the breast inherited?
Phyllodes tumor of the breast follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Phyllodes tumor of the breast typically begin?
Typical onset of Phyllodes tumor of the breast is adult. Age of onset can vary across affected individuals.
Which specialists treat Phyllodes tumor of the breast?
17 specialists and care centers treating Phyllodes tumor of the breast are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.